Status:
ACTIVE_NOT_RECRUITING
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
Lead Sponsor:
New World Medical, Inc.
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
A study of the Streamline Surgical System versus competitor
Eligibility Criteria
Inclusion
- Diagnosis of Mild to Moderate Primary Open Angle Glaucomma
Exclusion
- Other types of glaucoma including but not limited to: Normal tension glaucoma, pseudoexfoliative glaucoma, narrow angle glaucoma, traumatic, congenital, malignant, uveitic or neovascular glaucoma. Ocular hypertension.
Key Trial Info
Start Date :
February 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05280366
Start Date
February 9 2022
End Date
June 30 2026
Last Update
November 12 2024
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Vold Vision
Fayetteville, Arkansas, United States, 72704
2
Visionary Research Institute
Newport Beach, California, United States, 92663
3
Wolstan and Goldberg Eye Associates
Torrance, California, United States, 90505
4
University of Colorado
Aurora, Colorado, United States, 80045